Results 41 to 50 of about 867,932 (125)
ABSTRACT Introduction Although individual lifestyle interventions have shown promise in improving well‐being in patients with ulcerative colitis (UC), the feasibility of a multimodal approach remains unclear. This study assessed the feasibility of a multimodal lifestyle intervention programme.
Dorien Oomkens +7 more
wiley +1 more source
Mechanisms involved in the resistance of Mycobacterium tuberculosis to para-aminosalicylic acid
That para-aminobenzoic acid antagonizes competitively the inhibitory effect of para-aminosalicylic acid on the growth of Mycobac-terium tuberculosis is well known.
Loyd W. Hedgecock
core
The oxidation behavior of 3-aminosalicylic acid (3-ASA), 4-aminosalicylic acid (4-ASA) and 5-aminosalicyclic acid (5-ASA), the active part of the drugs Sulphasalazine and Dipentum for the treatment of ulcerative colitis, has been compared.
Nyholm, L,, Eriksson, A
core
Synthesis, characterization and radical scavenging activity of aromatic amine conjugates of 5-aminosalicylic acid [PDF]
5-Aminosalicylic acid is an anti-inflammatory drug used in the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn’s disease.
Jasmeen, S. +3 more
core +1 more source
Chemical structures of cyanidin-3-glucoside (A) and 5-aminosalicylic acid (B).
Chemical structures of cyanidin-3-glucoside (A) and 5-aminosalicylic acid (B).
Joana Paixão (455188) +4 more
core +1 more source
Structural landscape of multicomponent solids of 5-aminosalicylic acid
Crystallization of ten new multicomponent solids of 5-aminosalicylic acid with various inorganic and organic coformers has been achieved by mechanochemical and solvent evaporation techniques.
Ram Thaimattam +3 more
core +1 more source
Synthesis of Gold Nanoparticles Using p-Aminobenzoic Acid and p-Aminosalicylic Acid as Reducing Agent [PDF]
Synthesis of gold nanoparticles (AuNPs) by reduction of HAuCl4 with p-aminobenzoic acid and p-aminosalicylic acid as a reducing agent was investigated. This work was conducted in order to determine the optimum condition of AuNPs synthesis and examine the
Abdul Aji +2 more
core +1 more source
Derivatives of 4- or 5-aminosalicylic acid
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as ...
A. SPARATORE +5 more
core +1 more source
Para - Aminosalicylic Acid–Part iv
Summary After repeated exposure of M. tuberculosis H37RV to p-amino-salicylic acid for 10 months, no increase in resistance developed. Out of a total of 25 strains of M.
C L Goodacre, D E Seymour
core +1 more source
The aim of this study was to design and synthesize four colon-targeting mutual prodrugs of 5-aminosalicylic acid (5-ASA) and butyrate, and evaluate their therapeutic effects on ulcerative colitis.
Xianting Xie +6 more
core +1 more source

